Dr E. Alfonso Romero-Sandoval

      

Dr E. Alfonso Romero-Sandoval

Associate Editor: E. Alfonso Romero-Sandoval

Dr. Romero-Sandoval studies the molecular mechanisms of cannabinoid receptor activation in skin and immune cells in the induction of analgesia, resolution of inflammation, and promotion of tissue repair. The Romero-Sandoval laboratory explores the role of endocannabinoids in postoperative pain and its transition to persistent postoperative pain in addition to the function of phosphatases and kinases in spinal cord and the peripheral nervous system. Most recently Dr. Romero-Sandoval has focused on elucidating the role of macrophages in wound healing and the transition from acute to chronic pain in the context of diabetic neuropathy or surgical pain. The ultimate goal of the Romero-Sandoval lab is to restore the molecular mechanisms and cellular functions that are altered under pathological inflammatory and painful conditions. The Romero-Sandoval laboratory uses highly translatable clinical approaches such as the use of human primary cells, the use of clinically relevant functional assays, and the use of clinically tested nanotechnology for potential cell-directed gene therapies.  

Dr. Romero-Sandoval has held academic positions as Instructor (2007-2009) and Assistant Professor (2009-2012) at Geisel Dartmouth Medical School, Associate Professor and the Director of Research at Presbyterian College School of Pharmacy in Clinton, SC.
Currently (April 2017-present) he is an Associate Professor of Anesthesiology in the Pain Mechanisms Laboratory at Wake Forest University School of Medicine, Winston Salem, NC.